Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy

Background. Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagn...

Full description

Bibliographic Details
Main Authors: Zhihong Deng, Lu Chen, Jia Tan, Sha Wang, Dan Liu, Jinwei Wang, Chengzhi Jiang, Jie Yang, Bei Xu
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2021/9964232
id doaj-bc00bae15b6643b79d32ee819172156c
record_format Article
spelling doaj-bc00bae15b6643b79d32ee819172156c2021-05-31T00:32:43ZengHindawi LimitedDisease Markers1875-86302021-01-01202110.1155/2021/9964232Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic NeuropathyZhihong Deng0Lu Chen1Jia Tan2Sha Wang3Dan Liu4Jinwei Wang5Chengzhi Jiang6Jie Yang7Bei Xu8Department of OphthalmologyEye Center of Xiangya HospitalEye Center of Xiangya HospitalEye Center of Xiangya HospitalEye Center of Xiangya HospitalEye Center of Xiangya HospitalPET-CT CenterEye Center of Xiangya HospitalEye Center of Xiangya HospitalBackground. Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagnosis of DON. Methods. This retrospective cross-sectional study included 25 TED patients (50 eyes) with enlarged extraocular muscles, no previous anti-inflammatory therapy, and the absence of other vision-affecting diseases between May 2017 and August 2019. Baseline data, such as gender, age, ophthalmological history, thyroid disease and management, TED history including clinical features, management, and long-term results, ophthalmological examinations, serology examinations, and single-photon emission computed tomography/computed tomography (SPECT/CT) results, were extracted. The diagnostic criteria were as follows: (1) best-corrected visual acuity (BCVA) loss coexisting with either of the following—increased latency or reduction of amplitude on visual evoked potential (VEP), impaired color vision, visual field defects, contrast sensitivity impairment, and optic disk swelling—and (2) Barrett’s index≥60% in CT. Univariate and multivariate logistic regression analyses assessed the differences in age, gender, eyes, medical history, clinical activity, thyroid hormone and antibodies, uptake ratio (UR) of extraocular muscles in SPECT/CT, and volumetric orbital apex crowding index (VACI) using the generalized estimation equation. Consequently, the receiver operating characteristic curve (ROC) of the significant factors was constructed. Results. Univariate analysis revealed significant differences in the clinical activity, free triiodothyronine (FT3), free thyroxine (FT4), thyrotrophin receptor antibody (TRAb) levels, the UR of superior and medial rectus, and VACI between DON and TED (without DON) groups. Multivariate regression analysis revealed that TRAb and VACI were significantly different. ROC analysis showed that the univariate models of TRAb or VACI and the multivariate model were effective indicators of DON, while the multivariate model had the highest area under the ROC curve. Conclusion. A combination of TRAb and VACI is an effective indicator for DON.http://dx.doi.org/10.1155/2021/9964232
collection DOAJ
language English
format Article
sources DOAJ
author Zhihong Deng
Lu Chen
Jia Tan
Sha Wang
Dan Liu
Jinwei Wang
Chengzhi Jiang
Jie Yang
Bei Xu
spellingShingle Zhihong Deng
Lu Chen
Jia Tan
Sha Wang
Dan Liu
Jinwei Wang
Chengzhi Jiang
Jie Yang
Bei Xu
Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
Disease Markers
author_facet Zhihong Deng
Lu Chen
Jia Tan
Sha Wang
Dan Liu
Jinwei Wang
Chengzhi Jiang
Jie Yang
Bei Xu
author_sort Zhihong Deng
title Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_short Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_full Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_fullStr Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_full_unstemmed Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
title_sort combination model of thyrotrophin receptor antibody and volumetric orbital apex crowding index as an indicator of dysthyroid optic neuropathy
publisher Hindawi Limited
series Disease Markers
issn 1875-8630
publishDate 2021-01-01
description Background. Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. The present study was aimed at identifying new diagnostic factors for the accurate diagnosis of DON. Methods. This retrospective cross-sectional study included 25 TED patients (50 eyes) with enlarged extraocular muscles, no previous anti-inflammatory therapy, and the absence of other vision-affecting diseases between May 2017 and August 2019. Baseline data, such as gender, age, ophthalmological history, thyroid disease and management, TED history including clinical features, management, and long-term results, ophthalmological examinations, serology examinations, and single-photon emission computed tomography/computed tomography (SPECT/CT) results, were extracted. The diagnostic criteria were as follows: (1) best-corrected visual acuity (BCVA) loss coexisting with either of the following—increased latency or reduction of amplitude on visual evoked potential (VEP), impaired color vision, visual field defects, contrast sensitivity impairment, and optic disk swelling—and (2) Barrett’s index≥60% in CT. Univariate and multivariate logistic regression analyses assessed the differences in age, gender, eyes, medical history, clinical activity, thyroid hormone and antibodies, uptake ratio (UR) of extraocular muscles in SPECT/CT, and volumetric orbital apex crowding index (VACI) using the generalized estimation equation. Consequently, the receiver operating characteristic curve (ROC) of the significant factors was constructed. Results. Univariate analysis revealed significant differences in the clinical activity, free triiodothyronine (FT3), free thyroxine (FT4), thyrotrophin receptor antibody (TRAb) levels, the UR of superior and medial rectus, and VACI between DON and TED (without DON) groups. Multivariate regression analysis revealed that TRAb and VACI were significantly different. ROC analysis showed that the univariate models of TRAb or VACI and the multivariate model were effective indicators of DON, while the multivariate model had the highest area under the ROC curve. Conclusion. A combination of TRAb and VACI is an effective indicator for DON.
url http://dx.doi.org/10.1155/2021/9964232
work_keys_str_mv AT zhihongdeng combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT luchen combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT jiatan combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT shawang combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT danliu combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT jinweiwang combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT chengzhijiang combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT jieyang combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
AT beixu combinationmodelofthyrotrophinreceptorantibodyandvolumetricorbitalapexcrowdingindexasanindicatorofdysthyroidopticneuropathy
_version_ 1721419743323226112